Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Pleural Effusion, Malignant 4Breast Neoplasms 4Immunoglobulin Light-chain Amyloidosis 3Colorectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Pancreatic Neoplasms 2Neoplasm Metastasis 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Non-Hodgkin 2Exanthema 2Amyloidosis 2Waldenstrom Macroglobulinemia 1Urologic Neoplasms 1Tuberous Sclerosis 1Triple Negative Breast Neoplasms 1Tissue Adhesions 1Skin Toxicity 1Sezary Syndrome 1Ras-wildtype Colorectal Cancer 1Polyps 1Polycystic Ovary Syndrome 1Pleural Neoplasms 1Pain 1Ovarian Neoplasms 1Neurofibromatosis 2 1Neoplasms, Second Primary 1Neoplasms 1Myoma 1Menstruation Disturbances 1

Interventions

Doxycycline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Amyloidosis, Familial × Doxycycline × Clear all
NCT01677286 2017-08-01

Safety and Effect of Doxycycline in Patients With Amyloidosis

Boston University

Phase 2 Completed
25 enrolled 13 charts
Plasma cell

AA amyloidosis, Immunoglobulin Light-chain Amyloidosis, Amyloidosis, Amyloidosis, Familial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡